The Forest

Forest Neurotech is a deep-tech medical technology company developing a minimally invasive, high-bandwidth brain-computer interface (BCI) platform. The company's core technology, the Ultrasonic Neural Interface (UNI), utilizes ultrasound waves to both image and modulate neural activity across the entire brain with high precision. Unlike traditional electrode-based implants, the Forest 1 device is designed to be implanted beneath the skull but outside the brain tissue, reducing invasiveness while maintaining high-resolution data collection. The platform is currently being evaluated in clinical trials for circuit-level neurological and neuropsychological conditions, including treatment-resistant depression and epilepsy. Forest Neurotech operates as a research-focused entity and has spun off commercial ventures like Merge Labs to further scale its neurotechnology applications.